The US FDA's Controlled Substance Staff suggests rescheduling marijuana due to it meeting 3 criteria.

The US Food and Drug Administration's Controlled Substance Staff suggests rescheduling marijuana, based on it meeting 3 criteria: lower potential for abuse, accepted medical use, and low physical dependence. Reclassifying could have significant consequences on existing state laws, but the DEA's proposal requires White House review. Marijuana would still be a controlled substance.

April 30, 2024
9 Articles